Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TCP Group, originally founded as T.C. Pharmaceutical Industries, is a prominent Thai conglomerate best known as the developer and owner of the Red Bull energy drink brand. While globally recognized for its beverage portfolio, the company maintains a significant presence in the pharmaceutical and consumer healthcare sectors, manufacturing and distributing a variety of over-the-counter medicines and health supplements. The company operates integrated manufacturing facilities that comply with international standards, supporting its diverse range of energy drinks, functional beverages, and pharmaceutical products. TCP Group continues to expand its footprint across Asia and global markets through a combination of house brands and strategic partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on T.C. Pharmaceuticals.